ArticleFrontiers in oncology2024

Overexpression of serum HMGB1 and IDO in esophageal squamous cell carcinoma patients: potential clinical auxiliary diagnostic markers and immunotherapeutic targets.

Wenxuan Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.